What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Cancer
His primary scientific interests are in Primary biliary cirrhosis, Immunology, Internal medicine, Autoimmune disease and Gastroenterology.
His Primary biliary cirrhosis research includes themes of Anti-nuclear antibody, Antigen, Pathology, Primary sclerosing cholangitis and Genotype.
His Immunology study often links to related topics such as Cell biology.
Internal medicine is frequently linked to Surgery in his study.
The study incorporates disciplines such as Liver transplantation, Biliary cirrhosis, Intensive care medicine, Obeticholic acid and Heterogeneous group in addition to Gastroenterology.
His Immune system research incorporates elements of microRNA and Pathogenesis.
His most cited work include:
- Genomewide Association Study of Severe Covid-19 with Respiratory Failure. (594 citations)
- A Placebo-controlled trial of obeticholic acid in primary biliary cholangitis (461 citations)
- Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA) (424 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Primary biliary cirrhosis, Internal medicine, Immunology, Gastroenterology and Autoimmunity.
His Primary biliary cirrhosis research focuses on Cirrhosis and how it relates to Epidemiology.
In Internal medicine, Pietro Invernizzi works on issues like Endocrinology, which are connected to Cancer research.
His research is interdisciplinary, bridging the disciplines of Disease and Immunology.
The Disease study combines topics in areas such as Pathogenesis and Intensive care medicine.
The various areas that Pietro Invernizzi examines in his Gastroenterology study include Liver transplantation, Biliary cirrhosis, Obeticholic acid and Cohort.
He most often published in these fields:
- Primary biliary cirrhosis (47.24%)
- Internal medicine (45.71%)
- Immunology (46.32%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (45.71%)
- Gastroenterology (24.85%)
- Intensive care medicine (5.21%)
In recent papers he was focusing on the following fields of study:
Pietro Invernizzi mainly investigates Internal medicine, Gastroenterology, Intensive care medicine, Disease and In patient.
His Internal medicine research is multidisciplinary, relying on both Oncology and Alkaline phosphatase.
His Gastroenterology study combines topics from a wide range of disciplines, such as Primary sclerosing cholangitis, Cohort and Receiver operating characteristic.
His research in Intensive care medicine intersects with topics in Liver disease, Precision medicine, Serum transaminase and Transplantation.
His studies in Disease integrate themes in fields like Genetics, Genome-wide association study, Isocitrate dehydrogenase, Clinical trial and Tumor microenvironment.
Autoimmunity is the subject of his research, which falls under Immunology.
Between 2018 and 2021, his most popular works were:
- Genomewide Association Study of Severe Covid-19 with Respiratory Failure. (594 citations)
- Cholangiocarcinoma 2020: the next horizon in mechanisms and management (81 citations)
- High rates of 30-day mortality in patients with cirrhosis and COVID-19. (76 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Cancer
His main research concerns Internal medicine, Disease, Cirrhosis, Autoimmune hepatitis and Stem cell.
His research ties Endocrinology and Internal medicine together.
His Disease research integrates issues from Genome-wide association study, Tumor microenvironment, Case-control study, Respiratory failure and Meta-analysis.
He interconnects Liver transplantation, Liver function tests, Mortality rate, Hepatitis and Risk factor in the investigation of issues within Cirrhosis.
His Autoimmune hepatitis research incorporates themes from Biodistribution, Dexamethasone and Pharmacology, Drug.
His studies deal with areas such as Liver cancer, Cancer cell, Ferroptosis and Metabolism as well as Stem cell.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
